The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 06, 2022

Filed:

Jan. 30, 2017
Applicant:

Bonac Corporation, Kurume, JP;

Inventors:

Eriko Aoki, Kurume, JP;

Tadaaki Ohgi, Kurume, JP;

Takashi Kinoshita, Kurume, JP;

Assignee:

BONAC CORPORATION, Kurume, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 9/22 (2006.01); C12N 15/90 (2006.01); C07C 229/04 (2006.01); C07C 229/34 (2006.01); C12N 15/113 (2010.01); C07F 9/22 (2006.01); C40B 50/06 (2006.01);
U.S. Cl.
CPC ...
C12N 15/11 (2013.01); C07C 229/04 (2013.01); C07C 229/34 (2013.01); C07F 9/222 (2013.01); C12N 9/22 (2013.01); C12N 15/907 (2013.01); C40B 50/06 (2013.01); C12N 15/113 (2013.01); C12N 2310/20 (2017.05); C12N 2310/3181 (2013.01); C12N 2320/51 (2013.01); C12N 2330/30 (2013.01); C12N 2800/80 (2013.01);
Abstract

The invention provides an artificial sgRNA and a CRISPR/Cas9 system by combining the artificial sgRNA and Cas9. Activity of the sgRNA can be retained even when a nucleotide linker region for forming a single strand by linking the 3'-terminal of crRNA and the 5′-terminal of tracrRNA in sgRNA is substituted with an amino acid derivative linker, when the linker region existing between stem-loop 1 and stem-loop 2 of tracrRNA and/or the loop portion of stem-loop 2 are/is substituted with an amino acid derivative linker, or when an amino acid derivative linker is added/inserted into the vicinity of the 5′-terminal and/or the 3′-terminal of sgRNA. Stability in vivo can be improved by introducing one or more amino acid derivative linkers into the sgRNA.


Find Patent Forward Citations

Loading…